An Analysis of Deaths Caused by Cancer in Metropolitan Areas of Korea: Seoul, Pusan, Taegu, Incheon.
- Author:
Chae Un LEE
;
Joon Youn KIM
- Publication Type:Original Article
- MeSH:
Aged;
Bile Ducts;
Brain;
Busan*;
Certification;
Colonic Neoplasms;
Daegu*;
Epidemiologic Studies;
Esophagus;
Female;
Humans;
Incheon*;
Korea*;
Larynx;
Leukemia;
Liver;
Lung;
Male;
Mortality;
Pancreas;
Seoul*;
Stomach;
Thyroid Neoplasms;
Urinary Bladder;
Urinary Bladder Neoplasms;
Uterus
- From:Korean Journal of Preventive Medicine
1987;20(1):84-96
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
For the purpose of preparing the basic data for further cancer epidemiologic study and cancer patients control, we conducted the analysis on the degree and structure of deaths from cancer in metropolitan areas of Korea with 7,934 certified cancer deaths records of Seoul, Pusan, Taegu and Incheon in 1982. The analyzed results were as follows : 1) The total number of cancer deaths in metropolitan areas were 7,934 (male: 4,749, female: 3,185) as 14.1% of deaths from all causes in the same area. 2) The rate of physician's certification on cancer deaths was 77.4% and most of cancer deaths (84.4%) occurred at their home. 3) Cancer specific death rate was 51.7 per 100,000 population (male: 62.9, female: 41.9) and age-adjusted cancer death rate was 82.4 in male and 51.6 in female per 100,000 population. And the difference was statistically significant (p<0.01). 4) Age-specific cancer death rate was generally increased with age and most of cancer deaths (male: 75%, female: 65%) occurred from 45 to 74 years old. 5) The first three orders of cancer site were stomach (32.7%), liver (28.8%), lung (11.7%) in male and stomach (30.6%), uterus (18.4%), liver (13.8%) in female. And the relative frequency of these three cancer sites among total cancer deaths was corresponded to 73.2% in male and 62.8% in female. 6) The ratio of male to female cancer death rate was 1.5:1. And the ratio was above 3.0 in esophagus, liver, larynx, bladder cancer and the ratio was similar to 1.0 in stomach, pancreas, leukemia, brain, colon cancer, but the ratio was reversed in gall bladder and bile duct, and thyroid cancer.
